Hull University Teaching Hospitals NHS Trust

Hull HU32JZ

3 studies enrolling now · 10 studies all time

What they study most

COVID-19, Deep Vein Thrombosis, Diabetic Retinopathy, Fistulizing Crohns Disease, Geographic Atrophy, Inherited Retinal Diseases, KRAS G12C Lung Cancer, Kidney Disease, Macular Degeneration, Non-Small Cell Lung Cancer, Perianal Crohns Disease, Primary Biliary Cholangitis

Studies at this site

• A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer — Recruiting now
• A Study of Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy — Recruiting now
• Post-Market Celect Platinum Vena Cava Filter and Gunther Tulip Retrieval Set Study — Recruiting now
• A Study of Guselkumab in Participants With Fistulizing, Perianal Crohn's Disease — Running, not enrolling
• Global Patient Registry of Inherited Retinal Diseases — Running, not enrolling
• To Evaluate Safety and Tolerability of the Fixed- Dose Combination of Obeticholic Acid and Bezafibrate — Stopped early
• A Phase 3 Safety and Efficacy Study of Intravitreal Administration of Zimura (Complement C5 Inhibitor) — Completed
• A Study to Investigate the Efficacy and Safety of RG7774 in Patients With Diabetes Mellitus Type 1 or Type 2 With Treatment-Naive Diabetic Retinopathy — Completed
• Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734™) in Participants With Moderate Coronavirus Disease (COVID-19) Compared to Standard of Care Treatment — Completed
• Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734™) in Participants With Severe Coronavirus Disease (COVID-19) — Completed